Company fact sheet
Investor Alerts
Sign up to receive the latest Evocutis plc investor update news straight to your inbox.
Shares
The latest share information for Evocutis plc (EVO).
Reports
Downloadable versions of our annual and interim results.Evocutis plc is a leading dermatology company uniquely able to combine contract research for laboratory testing, advanced living skin models and clinical testing to offer a complete service for the development of skin care products and their ingredients.
Our aim is to advance the discovery of products through scientific development and validation within the cosmetic, personal care, pharmaceutical and medical device sectors.
We have ambitious growth targets. Our strategy for achieving long-term growth is:
- Building on our established reputation in skin expertise by further development of our advanced, specialist laboratory and clinical evaluations of skin care products for the health and cosmetic markets ;
- Out-licensing internally-developed technologies and selectively building skin care brands.
Founded:
2003 as a spin-out of the world-renowned Skin Centre at the University of Leeds
Country of Incorporation and Operation:
United Kingdom
Admission to AIM:
2006 as Syntopix Group plc (SYN). From 20 October 2011, as Evocutis plc (EVO).
Directors:
Tom Bannatyne (Non-executive Chairman), Dr Gwyn Humphreys (CEO), Dr Richard A Bojar (CSO), Darren Bamforth (Finance Director), and Mike Townend (Non-executive Director).
Website:
www.evocutis.com
Link to Press Kit:
www.evocutis.com/news/press-kit/
This includes a downloadable image gallery including Evocutis logo.
Contact details:
Evocutis plc
Sandbeck Lane, Wetherby, West Yorkshire, LS22 7TW, United Kingdom
Tel: +44 (0)844 209 8440